Monitoring of the status of both p53 alleles in patients with B-cell chronic lymphocytic leukemia - Relevance to prognosis and treatment

被引：0
|
作者：
Malcikova, J. [1 ]
Trbusek, M. [1 ]
Smardova, J. [1 ]
Cejkova, S. [1 ]
Kuglik, P. [1 ]
Brychtova, Y. [1 ]
Doubek, M. [1 ]
Dvorakova, D. [1 ]
Mayer, J. [1 ]
Pospisilova, S. [1 ]
机构：
[1] Univ Hosp Brno, Brno, Czech Republic
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0105
引用
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [1] p53 expression in B-cell chronic lymphocytic leukemia: A marker of disease progression and poor prognosis
    Cordone, I
    Masi, S
    Mauro, FR
    Soddu, S
    Morsilli, O
    Valentini, T
    Vegna, ML
    Guglielmi, C
    Mancini, F
    Giuliacci, S
    Sacchi, A
    Mandelli, F
    Foa, R
    BLOOD, 1998, 91 (11) : 4342 - 4349
  • [2] The impact of trisomy 12, retinoblastoma gene and P53 in prognosis of B-cell chronic lymphocytic leukemia
    AbdelSalam, M.
    El Sissy, A.
    Samra, M. A.
    Ibrahim, S.
    El Markaby, D.
    Gadallah, F.
    HEMATOLOGY, 2008, 13 (03) : 147 - 153
  • [3] Clinical significance of soluble p53 protein in B-cell chronic lymphocytic leukemia
    Del Principe, MI
    Del Poeta, G
    Venditti, A
    Buccisano, F
    Maurillo, L
    Marini, R
    Cox, MC
    Panetta, P
    Suppo, G
    Degan, M
    Bruno, A
    Gattei, V
    Amadori, S
    HAEMATOLOGICA, 2004, 89 (12) : 1468 - 1475
  • [4] PROGRESSIVE B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA FREQUENTLY EXHIBITS ABERRANT P53 EXPRESSION
    AGUILARSANTELISES, M
    MAGNUSSON, KP
    WIMAN, KG
    MELLSTEDT, H
    JONDAL, M
    INTERNATIONAL JOURNAL OF CANCER, 1994, 58 (04) : 474 - 479
  • [5] p53 dysfunction in B-cell chronic lymphocytic leukemia:: inactivation of ATM as an alternative to TP53 mutation
    Pettitt, AR
    Sherrington, PD
    Stewart, G
    Cawley, JC
    Taylor, AMR
    Stankovic, T
    BLOOD, 2001, 98 (03) : 814 - 822
  • [6] Targeting p53 in chronic lymphocytic leukemia
    Moia, Riccardo
    Boggione, Paola
    Mahmoud, Abdurraouf Mokhtar
    Kodipad, Ahad Ahmed
    Adhinaveni, Ramesh
    Sagiraju, Sruthi
    Patriarca, Andrea
    Gaidano, Gianluca
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2020, 24 (12) : 1239 - 1250
  • [7] p53 abnormalities in B-cell prolymphocytic leukemia
    Lens, D
    DeSchouwer, PJJC
    Hamoudi, RA
    AbdulRauf, M
    Farahat, N
    Matutes, E
    Crook, T
    Dyer, MJS
    Catovsky, D
    BLOOD, 1997, 89 (06) : 2015 - 2023
  • [8] A unique spectrum of p53 mutations in B-cell chronic lymphocytic leukemia distinct from that of other lymphoid malignancies
    Newcomb, EW
    ElRouby, S
    Thomas, A
    MOLECULAR CARCINOGENESIS, 1995, 14 (04) : 227 - 232
  • [9] NOVEL SMALL DELETIONS OF THE P53 GENE IN LATE-STAGE B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
    GANDINI, D
    AGUIARI, GL
    CUNEO, A
    PIVA, R
    CASTOLDI, GL
    DELSENNO, L
    BRITISH JOURNAL OF HAEMATOLOGY, 1994, 88 (04) : 881 - 885
  • [10] Efficacy of high-dose corticosteroid-based treatment for chronic lymphocytic leukemia patients with p53 abnormalities in the era of B-cell receptor inhibitors
    Pula, Bartosz
    Dlugosz-Danecka, Monika
    Salomon-Perzynski, Aleksander
    Szymczyk, Agnieszka
    Subocz, Edyta
    Budziszewska, Bozena Katarzyna
    Rybka, Justyna
    Gil, Lidia
    Waszczuk-Gajda, Anna
    Iskierka-Jazdzewska, Elzbieta
    Zaucha, Jan M.
    Osowiecki, Michal
    Piszczek, Weronika
    Steckiewicz, Pawel
    Szukalski, Lukasz
    Hus, Marek
    Lech-Maranda, Ewa
    Jurczak, Wojciech
    Jamroziak, Krzysztof
    ADVANCES IN MEDICAL SCIENCES, 2020, 65 (02): : 371 - 377
12345